HK Stock MarketDetailed Quotes
03309 C-MER MEDICAL
- 1.960
- 0.0000.00%
Market Closed Dec 20 16:08 CST
2.46BMarket Cap39.20P/E (TTM)
1.970High1.940Low936.00KVolume1.940Open1.960Pre Close1.83MTurnover0.08%Turnover Ratio40.00P/E (Static)1.26BShares3.48052wk High1.34P/B2.46BFloat Cap1.81052wk Low--Dividend TTM1.26BShs Float19.840Historical High--Dividend LFY1.53%Amplitude1.810Historical Low1.954Avg Price2000Lot Size--Div YieldTTM--Div Yield LFY
C-MER MEDICAL Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 1,206.88%124.27M | ---- | -141.77%-11.23M | ---- | 973.28%26.88M | ---- | -95.29%2.5M | ---- | -13.01%53.21M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -179.67%-19.89M | ---- | -58.93%-7.11M | ---- | 11.49%-4.48M | ---- | 62.50%-5.06M | ---- | -0.63%-13.48M |
| Attributable subsidiary (profit) loss | ---- | 91.63%-3.16M | ---- | -254.85%-37.8M | ---- | -3,959.42%-10.65M | ---- | 40.82%276K | ---- | --196K |
| Revaluation surplus: | ---- | -105.64%-1.87M | ---- | 298.79%33.22M | ---- | -45,064.86%-16.71M | ---- | 44.78%-37K | ---- | 11.84%-67K |
| -Other fair value changes | ---- | -105.64%-1.87M | ---- | 298.79%33.22M | ---- | -45,064.86%-16.71M | ---- | 44.78%-37K | ---- | 11.84%-67K |
| Asset sale loss (gain): | ---- | -71.53%121K | ---- | -91.69%425K | ---- | 14,108.33%5.12M | ---- | -74.47%36K | ---- | 1,381.82%141K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | --4.5M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -71.53%121K | ---- | -31.01%425K | ---- | 1,611.11%616K | ---- | -74.47%36K | ---- | 1,381.82%141K |
| Depreciation and amortization: | ---- | -1.36%220.99M | ---- | 50.78%224.03M | ---- | 30.84%148.58M | ---- | 44.59%113.56M | ---- | 207.44%78.54M |
| -Amortization of intangible assets | ---- | 7.63%1.54M | ---- | 20.30%1.43M | ---- | 33.97%1.19M | ---- | 33.03%886K | ---- | 41.40%666K |
| Financial expense | ---- | -7.80%18.12M | ---- | 51.26%19.66M | ---- | 25.53%13M | ---- | 37.44%10.35M | ---- | 4,607.50%7.53M |
| Special items | ---- | 211.33%4.15M | ---- | -64.95%1.33M | ---- | -40.38%3.8M | ---- | 30.90%6.38M | ---- | -25.57%4.87M |
| Operating profit before the change of operating capital | ---- | 54.01%342.72M | ---- | 34.43%222.53M | ---- | 29.30%165.53M | ---- | -2.23%128.02M | ---- | 63.81%130.94M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 237.06%11.87M | ---- | 6.00%-8.66M | ---- | -65.06%-9.21M | ---- | -52.20%-5.58M | ---- | -46.56%-3.67M |
| Accounts receivable (increase)decrease | ---- | 75.55%-6.53M | ---- | -43.98%-26.7M | ---- | -492.55%-18.54M | ---- | 28.77%-3.13M | ---- | -432.55%-4.39M |
| Accounts payable increase (decrease) | ---- | 566.87%34.92M | ---- | -126.02%-7.48M | ---- | 193.59%28.75M | ---- | -5.07%9.79M | ---- | 185.03%10.31M |
| prepayments (increase)decrease | ---- | 73.97%-6.61M | ---- | -681.73%-25.41M | ---- | -5.38%-3.25M | ---- | -139.29%-3.09M | ---- | 313.87%7.85M |
| Special items for working capital changes | ---- | -51.20%17.34M | ---- | 788.91%35.52M | ---- | -1,074.67%-5.16M | ---- | -87.85%529K | ---- | 3,450.00%4.36M |
| Cash from business operations | -25.87%150.69M | 107.43%393.7M | 99.02%203.28M | 20.04%189.8M | 0.10%102.14M | 24.95%158.12M | 246.89%102.04M | -12.97%126.54M | -60.44%29.42M | 131.44%145.4M |
| Other taxs | -93.62%-15.27M | -30.52%-32.55M | -222.72%-7.88M | -81.83%-24.94M | 79.22%-2.44M | 19.09%-13.72M | -47.41%-11.76M | -96.91%-16.95M | -113.46%-7.98M | 60.73%-8.61M |
| Net cash from operations | -30.69%135.43M | 119.06%361.15M | 95.99%195.4M | 14.17%164.86M | 10.43%99.7M | 31.76%144.4M | 321.10%90.28M | -19.88%109.59M | -69.64%21.44M | 234.42%136.79M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -21.67%6.94M | 179.67%19.89M | 555.70%8.87M | 58.93%7.11M | -45.22%1.35M | -6.63%4.48M | 25.92%2.47M | -57.57%4.79M | -70.15%1.96M | -3.53%11.3M |
| Dividend received - investment | --28.11M | ---- | ---- | --20.65M | --20.65M | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---23.2M | ---152.89M | ---- | ---- | ---- | ---1.01M | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | -104.17%-829K | 94.96%-1.58M | --19.87M | ---31.33M | ---- | ---- | 13.76%-73.36M | 5,643.60%253.68M | 74.00%-85.06M | 98.10%-4.58M |
| Sale of fixed assets | 279.57%3.55M | 1,056.13%14.52M | --935K | 13,855.56%1.26M | ---- | 800.00%9K | ---- | -99.61%1K | ---- | 27.72%258K |
| Purchase of fixed assets | -88.22%-84.04M | -29.75%-115.49M | -21.30%-44.65M | 24.66%-89.01M | 36.17%-36.81M | -275.17%-118.14M | 42.28%-57.67M | 74.65%-31.49M | -190.81%-99.91M | -291.93%-124.23M |
| Selling intangible assets | --151K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | -97.27%-651K | 83.30%-371K | 62.67%-330K | 79.97%-2.22M | 3.70%-884K | 94.14%-11.09M | 99.50%-918K | -297.07%-189.32M | -17,683.83%-184.77M | -2,280.33%-47.68M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---2.43M | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | -106.43%-152.89M | 60.14%-94.33M | -319.74%-74.06M | -501.91%-236.67M | -128.36%-17.65M | 61.92%-39.32M | 77.81%-7.73M | ---103.25M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.67%37K | ---- | 133.06%11.17M |
| Cash on investment | ---3.39M | -20.74%-9.45M | ---- | 74.64%-7.83M | ---- | 11.58%-30.87M | ---- | -1,354.79%-34.92M | ---54.93M | 85.46%-2.4M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---116.61M | ---- | ---- |
| Net cash from investment operations | 56.39%-73.35M | -25.38%-245.37M | -87.40%-168.2M | 50.55%-195.7M | 38.99%-89.75M | -158.40%-395.73M | 65.82%-147.12M | 40.96%-153.15M | -13.53%-430.44M | 5.53%-259.42M |
| Net cash before financing | 128.25%62.08M | 475.54%115.78M | 173.45%27.2M | 87.73%-30.83M | 117.50%9.95M | -477.01%-251.33M | 86.10%-56.83M | 64.48%-43.56M | -32.56%-409M | 47.53%-122.63M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -85.91%1.54M | -72.92%12.2M | 363.92%10.91M | -76.11%45.06M | -165.09%-4.13M | --188.6M | --6.35M | ---- | ---- | ---- |
| Refund | 98.45%-500K | 77.32%-44.06M | 82.15%-32.22M | -29,196.08%-194.23M | ---180.47M | ---663K | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | ---- | ---- | 6,470.76%607.66M | --491.81M | -97.68%9.25M | ---- | 24,567.20%399.36M | 25,752.81%418.56M | -99.75%1.62M |
| Interest paid - financing | -16.58%-10.57M | 11.56%-17.02M | 4.28%-9.07M | -48.05%-19.24M | -54.05%-9.47M | -25.53%-13M | -28.89%-6.15M | -37.44%-10.35M | -38.95%-4.77M | -4,607.50%-7.53M |
| Dividends paid - financing | 93.33%-200K | -266.67%-4.4M | -150.00%-3M | 94.78%-1.2M | 94.78%-1.2M | -6.75%-22.97M | -6.75%-22.97M | -2.33%-21.52M | ---21.52M | ---21.03M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | --800K | ---- | ---- | --6.68M |
| Issuance expenses and redemption of securities expenses | -721.69%-32.73M | -94.79%-58.29M | ---3.98M | ---29.93M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -1.40%-103.7M | -182.70%-242.88M | -142.55%-102.27M | 245.01%293.68M | 519.98%240.36M | -72.72%85.12M | -115.60%-57.23M | 568.45%312.02M | 2,006.33%366.91M | -110.57%-66.61M |
| Effect of rate | 9.57%-5.88M | -0.69%-4.84M | -23.64%-6.51M | -349.86%-4.81M | -564.52%-5.26M | -132.42%-1.07M | 130.40%1.13M | 1,084.18%3.3M | -302.77%-3.73M | 88.69%-335K |
| Net Cash | 44.56%-41.62M | -148.35%-127.09M | -129.99%-75.07M | 258.15%262.85M | 319.44%250.3M | -161.91%-166.21M | -170.99%-114.06M | 241.87%268.46M | 87.16%-42.09M | -147.70%-189.23M |
| Begining period cash | -20.46%512.76M | 66.74%644.7M | 66.74%644.7M | -30.20%386.66M | -30.20%386.66M | 96.31%553.93M | 96.31%553.93M | -40.18%282.18M | -40.18%282.18M | 505.04%471.75M |
| Cash at the end | -17.38%465.26M | -20.46%512.76M | -10.86%563.12M | 66.74%644.7M | 43.24%631.7M | -30.20%386.66M | 86.58%441M | 96.31%553.93M | 62.11%236.36M | -40.18%282.18M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
